News & Analysis on Clinical Trial Services & Contract Research And Development
Three of the world's biggest pharmaceutical companies have signed a landmark deal with the UK government that will see them use stem cell technology to road-test the safety of new compounds.
The era of human polyclonal antibodies has dawned as efforts get underway to produce the next generation therapeutics in transgenic chickens.
Researchers have, for the first time, unearthed a genetic variation that makes women more likely to suffer from the most extreme form of premenstrual tension or syndrome (PMT, PMS).
FMC BioPolymer has been forced to raise the price of its pharmaceutical grade cellulose by up to eight per cent to meet market pressures.
The excessive use of a popular influenza drug, and the associated build up of its waste in the environment, is heightening the risk of creating viruses in nature that are resistance to the therapy.
Finland-based Atacama Labs has launched its proprietary technology system for developing solid oral dosage forms.
Furious trading in shares of PDL BioPharma has taken place over the past couple of days as investors jumped in with both pockets open in the hope that a partner will soon be in the offing for the ailing firm.
German pharma firm Bayer is currently discussing with Indian company Biocon about a potential deal that would include the co-development of new biologics with an outsourcing element, according to Biocon.